Joseph Frattaroli - Net Worth and Insider Trading

Joseph Frattaroli Net Worth

The estimated net worth of Joseph Frattaroli is at least $14,507 dollars as of 2024-05-25. Joseph Frattaroli is the CFO of Inhibikase Therapeutics Inc and owns about 8,015 shares of Inhibikase Therapeutics Inc (IKT) stock worth over $14,507. Details can be seen in Joseph Frattaroli's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joseph Frattaroli has not made any transactions after 2022-05-19 and currently still holds the listed stock(s).

Transaction Summary of Joseph Frattaroli

To

Joseph Frattaroli Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joseph Frattaroli owns 1 companies in total, including Inhibikase Therapeutics Inc (IKT) .

Click here to see the complete history of Joseph Frattaroli’s form 4 insider trades.

Insider Ownership Summary of Joseph Frattaroli

Ticker Comapny Transaction Date Type of Owner
IKT Inhibikase Therapeutics Inc 2022-05-19 Cheif Financial Officer

Joseph Frattaroli Latest Holdings Summary

Joseph Frattaroli currently owns a total of 1 stock. Joseph Frattaroli owns 8,015 shares of Inhibikase Therapeutics Inc (IKT) as of May 19, 2022, with a value of $14,507.

Latest Holdings of Joseph Frattaroli

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IKT Inhibikase Therapeutics Inc 2022-05-19 8,015 1.81 14,507

Holding Weightings of Joseph Frattaroli


Joseph Frattaroli Form 4 Trading Tracker

According to the SEC Form 4 filings, Joseph Frattaroli has made a total of 1 transactions in Inhibikase Therapeutics Inc (IKT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Inhibikase Therapeutics Inc is the acquisition of 658 shares on May 19, 2022, which cost Joseph Frattaroli around $2,527.

Insider Trading History of Joseph Frattaroli

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joseph Frattaroli Trading Performance

GuruFocus tracks the stock performance after each of Joseph Frattaroli's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joseph Frattaroli is 19.83%. GuruFocus also compares Joseph Frattaroli's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joseph Frattaroli within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joseph Frattaroli's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joseph Frattaroli

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 38.1
Relative Return to S&P 500(%) 43.89

Joseph Frattaroli Ownership Network

Ownership Network List of Joseph Frattaroli

No Data

Ownership Network Relation of Joseph Frattaroli


Joseph Frattaroli Owned Company Details

What does Inhibikase Therapeutics Inc do?

Who are the key executives at Inhibikase Therapeutics Inc?

Joseph Frattaroli is the Cheif Financial Officer of Inhibikase Therapeutics Inc. Other key executives at Inhibikase Therapeutics Inc include director & 10 percent owner & President and CEO Milton H. Werner , and 10 percent owner Daniel Kalman .

Inhibikase Therapeutics Inc (IKT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Inhibikase Therapeutics Inc (IKT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Inhibikase Therapeutics Inc (IKT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Inhibikase Therapeutics Inc (IKT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inhibikase Therapeutics Inc Insider Transactions

No Available Data

Joseph Frattaroli Mailing Address

Above is the net worth, insider trading, and ownership report for Joseph Frattaroli. Currently GuruFocus does not have mailing address information for Joseph Frattaroli.

Discussions on Joseph Frattaroli

No discussions yet.